Skip to main content

fibroblast growth factor 23

The FGF23 gene provides instructions for making a protein called fibroblast growth factor 23, which is produced in bone cells. This protein helps regulate phosphate levels within the body. Among its many functions, phosphate plays a critical role in the formation and growth of bones during childhood and helps maintain bone strength in adults.

Video picks for Genes
Video library

Normal function

The FGF23 gene provides instructions for making a protein called fibroblast growth factor 23, which is produced in bone cells. This protein helps regulate phosphate levels within the body. Among its many functions, phosphate plays a critical role in the formation and growth of bones during childhood and helps maintain bone strength in adults.

Fibroblast growth factor 23 works in the kidneys to keep the body's phosphate levels in balance. The kidneys normally release excess phosphate in the urine, and they reabsorb this mineral into the bloodstream when more is needed. Fibroblast growth factor 23 acts as a signal that tells the kidneys to stop reabsorbing phosphate into the bloodstream.

In order for fibroblast growth factor 23 to function, sugar molecules must attach to the protein through a process called glycosylation. This allows fibroblast growth factor 23 to move out of the bone cell and protects it from being broken down. Once outside the cell, fibroblast growth factor 23 must bind to a receptor protein that spans the membrane of kidney cells. Binding to this receptor triggers a signaling pathway that stops phosphate reabsorption by the kidneys. When more phosphate is needed, fibroblast growth factor 23 is cut (cleaved) at a certain site, which turns off (inactivates) the protein. This helps regulate the amount of active fibroblast growth factor 23 that is circulating in the bloodstream.

Conditions referring to this gene or chromosome

Patient picks for Genes

Related patient information and medicines

Localised scleroderma

Patient information leaflet

Localised scleroderma

Generalised morphoea symptoms This is a rare type where there are more plaques spread around different areas of the body. Causes of localised scleroderma The cause is not clear. What is known is that cells called fibroblasts make too much of a protein called collagen. The collagen gets deposited in the skin, causing scarring and thickening.

Chronic sinusitis

Patient information leaflet

Chronic sinusitis

Other medical conditions Sometimes, chronic sinusitis can develop as a result of another medical condition. Examples include: Cystic fibrosis Cystic fibrosis , a genetic condition which causes thick mucus that is difficult to clear from the lungs, sinuses, and elsewhere. Granulomatosis with polyangiitis Granulomatosis with polyangiitis , a rare.

Breast cancer

Patient information leaflet

Breast cancer

...acebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest: [https://uk.pinterest.com/patient/](https://uk.pinterest.com/patient/) Instagram: [https://www.instagram.com/patient.info/](https://www.instagram.com/patient.info/) Breast cancer is one of the most common.

Molar pregnancy

Patient information leaflet

Molar pregnancy

Dr Sarah Jarvis MBE A hydatidiform mole is a growing mass of tissue inside your womb (uterus) that will not develop into a baby. It is the result of abnormal conception. It may cause b... A molar pregnancy is part of a group of disorders called gestational trophoblastic disease (GTD). The trophoblast is the outer layer of cells around an embryo,.

Diabetic retinopathy

Patient information leaflet

Diabetic retinopathy

Stage 2: pre-proliferative retinopathy Pre-proliferative retinopathy is m... There are signs of blood flow becoming restricted but not yet showing new blood vessels growing (see below). Stage 3: proliferative retinopathy Proliferative retinopathy is the advanced diabetic retinopathy that occurs when damaged blood vessels in the retina make.

Throat cancer

Patient information leaflet

Throat cancer

(The throat is usually sprayed with a local anaesthetic before use of a nasal endoscope, so that the procedure i... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 16 Mar 2026 | Latest version
  • 1 Mar 2026 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.